The musearlnie receptors are currently divided into at least three subtypes: M 1 , M 2 a and M 2 ß (for recent reviews, see Eglen and Whiting, 1986; Mutschier et al., 1987; 1988) . M 1 -Receptors are found in high density in neuronal tissues such as autonomic ganglia, cerebral cortex and hippocampus, whereas M 2 -receptors are mainly present in lower brain areas and in peripheral effector organs such as heart (M 2 a) and smooth musdes (M 2 ß) as weil as glands (M 2 ß). Their different affinities for selective muscarinic antagonists such as pirenzepine (M 1 >> M 2 a = M 2 ß; Hammer and Giachetti, 1982; Mutschier et al., 1987; 1988) and methoctramine (M 2 a > M 1 > M 2 ß; Mutschier et al., 1988) are a major characteristic of these subtypes. Recent structure-selectivity relationship sturlies of a series of difenidol and hexocyclium analogues have led to the discovery of novel muscarinic antagonists, hexahydro-sila-difenidol (M 1 = M 2 ß >> M 2 a) and sila-hexocyclium (SiHC; M 1 ::::: M 2 ß > M 2 a) (Mutschler et al., 1987; 1988) , which display a high selectivity in blocking smooth muscle and glandular M 2 ß-receptors in comparison to cardiac M 2 a-receptors. We report here on the unique pharmacological profile of o-methoxysila-hexocyclium (o-MeSiHC; 4-{[cyclohexylhy-
The musearlnie receptors are currently divided into at least three subtypes: M 1 , M 2 a and M 2 ß (for recent reviews, see Eglen and Whiting, 1986; Mutschier et al., 1987; 1988) . M 1 -Receptors are found in high density in neuronal tissues such as autonomic ganglia, cerebral cortex and hippocampus, whereas M 2 -receptors are mainly present in lower brain areas and in peripheral effector organs such as heart (M 2 a) and smooth musdes (M 2 ß) as weil as glands (M 2 ß). Their different affinities for selective muscarinic antagonists such as pirenzepine (M 1 >> M 2 a = M 2 ß; Hammer and Giachetti, 1982; Mutschier et al., 1987; 1988) and methoctramine (M 2 a > M 1 > M 2 ß; Mutschier et al., 1988) are a major characteristic of these subtypes. Recent structure-selectivity relationship sturlies of a series of difenidol and hexocyclium analogues have led to the discovery of novel muscarinic antagonists, hexahydro-sila-difenidol (M 1 = M 2 ß >> M 2 a) and sila-hexocyclium (SiHC; M 1 ::::: M 2 ß > M 2 a) (Mutschler et al., 1987; 1988) , which display a high selectivity in blocking smooth muscle and glandular M 2 ß-receptors in comparison to cardiac M 2 a-receptors. We report here on the unique pharmacological profile of o-methoxysila-hexocyclium (o-MeSiHC; 4-{[cyclohexylhy-
• To whom all correspondence should be addressed: Depart· ment of Phannacology, University of Frankfurt, TheodorStem.Kai 7, Gebäude 75A, 0·6000 FrankfurtjM, F.R.G.
droxy(2-methoxyphenyl)silyl]methyl} -1, 1-dimethylpiperazinium methyl sulfate) which ex.hibits a spectrum of selectivity different from that of the parent compound (SiHC). To the best of our knowledge, o-MeSiHC is the first quaternary antimuscarinic agent which shows high M 1 -receptor selectivity.
Experiments on ganglia were performed as described by Brown et al. (1980) . Briefly, superior cervical ganglia were isolated from rats anaesthetised with urethane. The ganglia were suspended in separate heated chambers (36 ° C) and superfused with oxygenated (5% C0 2 , 95% 0 2 ) Krebs solution (composition in mmoljl: NaC1124; KCl 3; NaHC0 3 26; NaH 2 P0 4 1.25; CaC1 2 2; MgC1 2 2; ( + )-glucose 10). Muscarine-induced (pD 2 = 7.4) depolarisation was recorded differentially, via calomel electrodes, between the ganglion and its postganglionic trunk. Semicumulative dose-response curves for muscarine were obtained and the antagonists pirenzepine and o-MeSiHC were pre-equilibrated for 30 min. Left atria and strips of ileallongitudinal muscle from adult guinea-pigs were incubated under 0.5 g tension in 6 ml oxygenated (5% C0 2 , 95% 0 2 ) Tyrode solution (32°C; composition in mmoljl: NaCl 137; KCI 2.7; CaC1 2 1.8; MgC1 2 1.05; NaHC0 3 11.9; NaH 2 P0 4 0.42; ( + )-glucose 5.6). The atria were paced electrically at 120 beatsjmin. The ileum contractions and negative inotropic responses of the atria were recorded with a force-displacement TABLE 1 Comparison of the pA 2 values for pirenzepine (Pz) and omethoxy-sila-hexocyclium (o-MeSiHC) at muscarinic M 1 -receptors of rat superior cervical ganglia and at M rreceptors of guinea-pig ileum (M 2 p) and atria (M 2 a). Dose-response curves to muscarine (ganglia) and arecaidine propargyl ester (ileum and atria) were obtained and dose ratios were estimated for antagonist-induced parallel shifts in these curves. pA 2 values were determined from Schild plots constrained to slope -1.0. The experimental data generated regression lines whose derived slopes were not signifieantly different from unity. The results are presented as means ± S.E.M. of 9-12 experiments on eaeh preparation. transducer on a Helcoscriptor. Cumulative doseresponse curves to arecaidine propargyl ester (pD 2 -atria = 8.1; pD 2 -ileum = 7.5) (Mutschler et al., 1988) were obtained before and after the addi tion of an antagonist which was allowed to equilibrate for 30 min. At least three concentrations of antagonists were tested in the three tissues and dose ratios were estimated for antagonist-induced parallel shifts in the agonist dose-response curves. Schild plots were made, using linear regression, by the method of least squares. The slopes of these plots were not significantly different from unity. The pA 2 values (table 1) were estimated by fitting to the data the best straight line with a slope equal to unity. Pirenzepine and o-MeSiHC proved tobe competitive antagonists at ganglionic M 1 -, cardiac M 2 a-and ileal M 2 ß-receptors. Different selectivity pattems were observed; pirenzepine: M 1 >> M 2 a = M 2 ß, o-MeSiHC: M 1 >> M 2 ß > M 2 a. A 24-fold difference in pA 2 value was determined for both antagonists on the rat superior cervical ganglion (8.3. This value was very close to the pA 2 value of 8.36 for pirenzepine determined by Brown et al. (1980) ) compared with the ileum (6.9). Pirenzepine exhibited similar affinities for cardiac M 2 a-and ileal M 2 ß-receptors. In contrast, the affinity obtained for o-MeSiHC was significantly lower at M 2 a-receptors in atria than at M 2 ß-receptors in the ileum. Thus, the selectivity of pirenzepine and o-MeSiHC for M 1 -over M 2 a-receptors is 30-and 78-fold, respectively.
In conclusion, o-MeSiHC is a potent M 1 -selective muscarinic antagonist and could be a useful new tool to further investigate muscarinic receptor heterogeneity. o-MeSiHC is the first quaternary ammonium compound with high M 1 -receptor selectivi ty. I t has the advantage over pirenzepine that its selectivity for M 1 -over M 2 a-receptors is higher.
